Health investors struggle under weight of Washington's what-ifs

Optimism is in short supply when it comes to health-care stocks as investors can’t see when the sector will recover from an array of regulatory threats. Plagued by concerns about drug pricing and jitters over proposals for a U.S. government-run system, health care has gone from the top-performing group in the S&P 500 Index last year to its worst in 2019.